Podcast: All About Unlocking Eve – The Initiative Advancing Women In Healthcare Leadership

In Vivo sat down with Eva McLellan and Kaye Vitug to discuss Unlocking Eve, an initiative to bring more women into positions of healthcare leadership

In Vivo's Chloe Kent discussed the future of women in healthcare leadership with Roche executives and Unlocking Eve founders Eva McLellan and Kaye Vitug.

Self-described as a "movement for transformational change", Unlocking Eve is an initiative which focuses on elevating women in leadership and decision-making roles throughout the healthcare space. Founded by senior Roche Holding AG executives Eva McLellan and Kaye Vitug, the organization recently hosted its debut panel event at the 2022 World Economic Forum in Davos.

In Vivo reporter Chloe Kent sat down with the founders to discuss why women are so underrepresented healthcare leadership, and...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Diversity & Inclusion

How to create a story in Arc

 
• By 

Although pharmaceuticals are exempt from the US reciprocal tariff policy, for now, the escalating global trade war is already posing practical on-the-ground problems for some companies, In Vivo investigates.

Medtechs Are Fully Engaged In Climate Change: ‘They Have No Choice’

 
• By 

The E in ESG: SUDs, reuse, disposables, refurbishing, reprocessed devices? Multiple panelists at the 2024 MedTech Forum addressed the role medtech manufacturers should have in the climate change challenge.

16 Key Trends Reshaping The Future Of Medtech

 
• By 

Record attendance at the 2024 MedTech Forum in Vienna heard industry leaders voice optimism grounded in realism about future developments for Europe’s medtech industry, markets and delivery of care to patients. In Vivo filtered out 16 trends to watch.

South Korea Sees Pharma Leadership Transition

 
• By 

Leadership succession is proceeding within South Korean pharmaceutical corporations such as Daiichi Sankyo Korea, Astellas Pharma Korea, Kyowa Kirin Korea as well as MSD Korea.  

More from ESG

Medtechs Are Fully Engaged In Climate Change: ‘They Have No Choice’

 
• By 

The E in ESG: SUDs, reuse, disposables, refurbishing, reprocessed devices? Multiple panelists at the 2024 MedTech Forum addressed the role medtech manufacturers should have in the climate change challenge.

Podcast: Navigating Challenges – The Changing Role Of Big Pharma

 

Stefan Woxström, senior vice president of AstraZeneca, Europe and Canada, discusses the growing challenges in the industry and addresses the role big pharma must adopt in resolving them.

16 Key Trends Reshaping The Future Of Medtech

 
• By 

Record attendance at the 2024 MedTech Forum in Vienna heard industry leaders voice optimism grounded in realism about future developments for Europe’s medtech industry, markets and delivery of care to patients. In Vivo filtered out 16 trends to watch.